Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

894 public trials 110 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Recruiting

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

NCT06593145

Conditions: Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego - Centralny Szpital Kliniczny Warsaw, Ul. Banacha 1a, Poland

Uniwersyteckie Centrum Kliniczne Gdańskiego Uniwersytetu Medycznego - Katedra i Klinika Hematologii i Transplantologii Gdansk, Ul. Smoluchowskiego 17, Poland

View Trial Details

Recruiting

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

NCT06341556

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

NCT05255354

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Stanford Cancer Center Palo Alto, California, United States

View Trial Details

Recruiting

Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment

NCT06496308

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

NCT06482684

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Hospital of Mainz Mainz, Germany

Klinikum der Universität München Munich, Germany

View Trial Details

Recruiting

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

NCT05868395

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: AKH Vienna, Division of Oncology Department of Medicine I Vienna, Austria

View Trial Details

Recruiting

Italian Observational Study on CAR-T Therapy for Lymphoma

NCT06339255

Conditions: Diffuse Low Grade B-Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy

View Trial Details

Recruiting

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.

NCT05833763

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peter MacCallum Cancer Centre Parkville, Victoria, Australia

Sir Charles Gairdener Nedlands, Western Australia, Australia

View Trial Details

Recruiting

A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT06136351

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

REal World Data in LYmphoma and Survival in Adults

NCT03869619

Conditions: Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
Locations: Unité d'Hématologie Clinique, CH D'ARRAS Arras, France

Service d'Hématologie, CHU Jean Minjoz Besançon, France

Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France

Institut Bergonié Bordeaux, France

View all 37 locations

View Trial Details